Auro Labs.

{
  "main_header": {
    "sid": 239365,
    "name": "Auro Labs.",
    "stock_name": "Auro Labs.",
    "full_name": "Auro Laboratories Ltd",
    "name_url": "stocks-analysis/auro-labs",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "249.85",
    "chg": 24.55,
    "chgp": "10.9%",
    "dir": 1,
    "prev_price": "225.30",
    "mcapval": "147.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 530233,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE292C01011",
    "curr_date": "Feb 03",
    "curr_time": "",
    "bse_nse_vol": "7.77 k",
    "exc_status": "Active",
    "traded_date": "Feb 03, 2026",
    "traded_date_str": "2026 02 03",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/auro-labs-239365-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Auro Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-3817923",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AuroLaboratorie_mojoScore_3817923.png",
        "date": "2026-02-03 10:12:09",
        "description": "Auro Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Why is Auro Laboratories Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-auro-laboratories-ltd-fallingrising-3810344",
        "imagepath": "",
        "date": "2026-01-30 00:46:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Performance and Market Context</strong></p>\n<p>On the day in question, Auro Laboratories outperformed its sector by 7.99%, marking a strong rebound after a period of underperformance. The stock has been on a positive trajectory for two consecutive days, delivering a cumulative return of 12.31% during this short span. It opened with a gap up of 2.81% and reached an intraday high of ₹241.95, representing an 11.29% increase from the previous close. These gains indicate renewed investor interest and buying momentum, supported by rising delivery volumes which increased by 1.46% compared to the five-day average.</p>\n<p>Despite this recent surge, the stock’s medium-term performance remains subdued. Over the past month and year-to-date, the share price has declined by 6.64% and 6.71% re..."
      },
      {
        "title": "When is the next results date for Auro Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-auro-laboratories-ltd-3810220",
        "imagepath": "",
        "date": "2026-01-29 23:15:57",
        "description": "The next results date for Auro Laboratories Ltd is scheduled for 05 February 2026...."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-3801498",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AuroLaboratorie_mojoScore_3801498.png",
        "date": "2026-01-23 10:10:03",
        "description": "Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Auro Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-is-rated-sell-3789813",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AuroLaboratorie_mojoScore_3789813.png",
        "date": "2026-01-12 10:10:03",
        "description": "Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Auro Laboratories Ltd Downgraded to Sell Amidst Weak Financials and Technical Setbacks",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-ltd-downgraded-to-sell-amidst-weak-financials-and-technical-setbacks-3774157",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AuroLaboratorie_mojoScore_3774157.png",
        "date": "2025-12-30 08:08:56",
        "description": "Auro Laboratories Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 29 Dec 2025, reflecting a deterioration in its technical outlook alongside persistent financial challenges. The company’s Mojo Score has declined to 41.0, signalling caution for investors amid flat quarterly results, weak debt servicing ability, and a sideways technical trend."
      },
      {
        "title": "Auro Laboratories Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-laboratories-upgraded-to-hold-by-marketsmojo-amid-mixed-financial-and-technical-signals-3766409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AuroLaboratorie_mojoScore_3766409.png",
        "date": "2025-12-23 08:09:44",
        "description": "Auro Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation following recent changes in its technical outlook and financial performance. While the company’s long-term returns remain impressive compared to broader market indices, mixed signals from valuation metrics and financial trends have influenced the latest assessment of its investment profile."
      },
      {
        "title": "Auro Labs. Sees Revision in Market Assessment Amid Mixed Financial Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/auro-labs-upgraded-from-strong-sell-to-sell-by-marketsmojo-on-30-sep-2025-3746471",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/AuroLabs_mojoScore_3746471.png",
        "date": "2025-12-04 11:08:19",
        "description": "Auro Labs., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid a backdrop of mixed performance indicators, including valuation concerns and subdued financial trends, which continue to shape investor perspectives."
      },
      {
        "title": "Auro Laboratories Surges with Unprecedented Buying Interest, Hits Upper Circuit",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/auro-laboratories-hits-upper-circuit-amidst-unprecedented-buying-frenzy-3718286",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/AuroLaboratorie_only_buyers_3718286.png",
        "date": "2025-11-20 14:20:29",
        "description": "Auro Laboratories Ltd has witnessed extraordinary buying momentum today, registering a sharp surge that propelled the stock to hit its upper circuit limit. The absence of sellers and a queue filled exclusively with buy orders signal a potential multi-day circuit scenario, underscoring robust investor interest in this Pharmaceuticals & Biotechnology company."
      }
    ],
    "total": 139,
    "sid": "239365",
    "stock_news_url": "https://www.marketsmojo.com/news/auro-laboratories-239365"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Unaudited Financial Results For Quarter Ended December 31 2025.",
      "datetime": "28-Jan-2026",
      "details": "Auro Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 inter alia to consider and approve Unaudited Financial Results for the quarter ended December 31 2025 and any other matter with the permission of Chair.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "14-Jan-2026",
      "details": "Auro Laboratories Limited has submitted the Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018 for quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "26-Dec-2025",
      "details": "Intimation of Closure of Trading Window",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "05 Feb 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Auro Laboratories Ltd is Rated Sell

2026-02-03 10:12:09

Auro Laboratories Ltd is rated Sell by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 03 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Why is Auro Laboratories Ltd falling/rising?

2026-01-30 00:46:48

Recent Price Performance and Market Context

On the day in question, Auro Laboratories outperformed its sector by 7.99%, marking a strong rebound after a period of underperformance. The stock has been on a positive trajectory for two consecutive days, delivering a cumulative return of 12.31% during this short span. It opened with a gap up of 2.81% and reached an intraday high of ₹241.95, representing an 11.29% increase from the previous close. These gains indicate renewed investor interest and buying momentum, supported by rising delivery volumes which increased by 1.46% compared to the five-day average.

Despite this recent surge, the stock’s medium-term performance remains subdued. Over the past month and year-to-date, the share price has declined by 6.64% and 6.71% re...

Read full news article

When is the next results date for Auro Laboratories Ltd?

2026-01-29 23:15:57

The next results date for Auro Laboratories Ltd is scheduled for 05 February 2026....

Read full news article

Auro Laboratories Ltd is Rated Sell

2026-01-23 10:10:03

Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Auro Laboratories Ltd is Rated Sell

2026-01-12 10:10:03

Auro Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 29 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Auro Laboratories Ltd Downgraded to Sell Amidst Weak Financials and Technical Setbacks

2025-12-30 08:08:56

Auro Laboratories Ltd has been downgraded from a Hold to a Sell rating by MarketsMOJO as of 29 Dec 2025, reflecting a deterioration in its technical outlook alongside persistent financial challenges. The company’s Mojo Score has declined to 41.0, signalling caution for investors amid flat quarterly results, weak debt servicing ability, and a sideways technical trend.

Read full news article

Auro Laboratories Sees Shift in Market Assessment Amid Mixed Financial and Technical Signals

2025-12-23 08:09:44

Auro Laboratories, a key player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its market evaluation following recent changes in its technical outlook and financial performance. While the company’s long-term returns remain impressive compared to broader market indices, mixed signals from valuation metrics and financial trends have influenced the latest assessment of its investment profile.

Read full news article

Auro Labs. Sees Revision in Market Assessment Amid Mixed Financial Signals

2025-12-04 11:08:19

Auro Labs., a microcap player in the Pharmaceuticals & Biotechnology sector, has experienced a revision in its market evaluation reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid a backdrop of mixed performance indicators, including valuation concerns and subdued financial trends, which continue to shape investor perspectives.

Read full news article

Auro Laboratories Surges with Unprecedented Buying Interest, Hits Upper Circuit

2025-11-20 14:20:29

Auro Laboratories Ltd has witnessed extraordinary buying momentum today, registering a sharp surge that propelled the stock to hit its upper circuit limit. The absence of sellers and a queue filled exclusively with buy orders signal a potential multi-day circuit scenario, underscoring robust investor interest in this Pharmaceuticals & Biotechnology company.

Read full news article

View All News